Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

Abstract

The combination of vinorelbine and gemcitabine is an active scheme in pretreated MBC, demonstrating an acceptable toxicity profile, and may well represent a valuable therapeutic choice after anthracycline/taxane regimens.